- Home
- DYN vs CTS Comparison
DYN vs CTS Comparison
Compare DYN & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- CTS
- Stock Information
- Founded
- DYN 1984
- CTS 1896
- Country
- DYN United States
- CTS United States
- Employees
- DYN N/A
- CTS N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- CTS Electrical Products
- Sector
- DYN Health Care
- CTS Technology
- Exchange
- DYN Nasdaq
- CTS Nasdaq
- Market Cap
- DYN 1.4B
- CTS 1.3B
- IPO Year
- DYN 2020
- CTS N/A
- Fundamental
- Price
- DYN $9.57
- CTS $43.43
- Analyst Decision
- DYN Strong Buy
- CTS
- Analyst Count
- DYN 15
- CTS 0
- Target Price
- DYN $43.60
- CTS N/A
- AVG Volume (30 Days)
- DYN 2.7M
- CTS 138.6K
- Earning Date
- DYN 08-11-2025
- CTS 07-29-2025
- Dividend Yield
- DYN N/A
- CTS 0.37%
- EPS Growth
- DYN N/A
- CTS 16.02
- EPS
- DYN N/A
- CTS 1.97
- Revenue
- DYN N/A
- CTS $515,789,999.00
- Revenue This Year
- DYN N/A
- CTS $4.41
- Revenue Next Year
- DYN N/A
- CTS $7.00
- P/E Ratio
- DYN N/A
- CTS $22.12
- Revenue Growth
- DYN N/A
- CTS N/A
- 52 Week Low
- DYN $6.36
- CTS $34.02
- 52 Week High
- DYN $47.45
- CTS $59.68
- Technical
- Relative Strength Index (RSI)
- DYN 32.17
- CTS 60.09
- Support Level
- DYN $10.00
- CTS $40.77
- Resistance Level
- DYN $10.74
- CTS $43.70
- Average True Range (ATR)
- DYN 0.88
- CTS 0.86
- MACD
- DYN -0.48
- CTS 0.10
- Stochastic Oscillator
- DYN 0.53
- CTS 89.76
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.